Standard Web Site
Home Page
About us
Contact us
Donations and sponsorship

Ankylosing Spondylitis Research

This site summarizes the latest research in AS

This site is
sponsored by :


NASS
(National Ankylosing
Spondylitis Society)
 
 
 
 

Medication use in Ankylosing Spondylitis: Sulfasalazine

What is Sulfasalazine?

It is a combination molecule in which 5 amino salicylic acid (the compound that makes up aspirin) is joined with sulfapyridine (an anti-bacterial agent). Small amounts of the drug are taken up in the stomach but a major portion of it reaches the large bowel intact where, it is split into the individual portions. The sulfapyridine part is absorbed and broken down in the liver, it is this portion of the drug that is useful in the management of inflammation of the joints. The 5 aminosalicylate part remains in the large intestine and is useful in managing the inflammation of the bowel such as Ulcerative colitis.

What is the role of sulfasalazine in the management of Ankylosing Spondylitis?

Sulfasalazine is the best studied disease modifying agent, used as a second line treatment in Spondyloarthropathy. Its efficacy in the treatment of AS remains unclear. Analysis of the trials conducted in AS show that treatment with Sulfasalazine had significant improvement in patients with AS in their hands, feet, shoulders etc but it was ineffective in patients with axial involvement (back symptoms) only.

How does sulfasalazine reduce inflammation in the joints?

 

The exact mechanism of action is not known. It appears to have an effect in lowering inflammation. This may be because it affects folic acid breakdown. Folic acid is needed for rapidly multiplying cells and since the inflammatory cells have a short life, there are the ones most affected. There is also evidence for anti-bacterial (in the colon) effects of sulfasalizine

How is sulfasalazine given and what are the possible side effects ?

Sulfasalazine is to be avoided in patients who are known to be allergic to sulfa group of drugs or have a condition called porphyria. It is available in the form of tablets which are enteric coated (a covering), to reduced the irritation to the stomach. The tablets are available in strengths of 500 mgs and are started in a dose of 1 tablet a day and slowly increased by one tablet a week to final dose of 4-6 tablets per day. The treatment is to be continued as long as possible though, the number of people who remain on Sulfasalazine after 5 years) is about 40% (ie 2 in 5 people).

The common side effects include skin rash, feeling sick (nausea), diarrhea, loss of appetite, heartburn, abdominal pain, dizziness, headache and reduction in the blood counts (meaning fewer blood cells). Symptoms such as sore throat, fever, any other infection or an unexplained bruising should prompt a visit to your GP. There may be a change in the colour of your urine (it may change to orange) and sulfasalazine may stain soft contact lenses yellow. A transient reduction in the sperm count resulting a temporary reduced fertility is seen in about 80% of men receiving the drug. These adverse events usually improve on stopping the drugs. To reduce the incidence of side effects these tablets are enteric coated and the dose is built up slowly.

Are regular blood tests required?

Before starting the drug a doctor will make sure you have a full blood count, liver function tests and renal (kidney) function tests. Since most of the side effects occur in the initial six months of therapy, regular monthly blood test are conducted for that period. After which the occurrence of side effects are not as common and so such frequent testing is not required.

[Top of page]


[
Email]

This site is sponsored by : NASS(National Ankylosing Spondylitis Society) | Web Hosting sponsored by Ark Computer Consultancy Ltd